Back to Search
DR. VALERIE A BAIN MD
MD
Family Medicine Physician
NPI: 1659690311IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
47157(CO)
Education
UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE
Class of 2007
Research & Publications (20)
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients.
PMID 16487617·J Hepatol·2006
3-trial
Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study.
PMID 19490420·Liver Int·2009
3-trial
Prediction of cardiac complications after liver transplantation.
PMID 19295324·Transplantation·2009
8-other
A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.
PMID 19471253·Am J Gastroenterol·2009
4-observational
The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.
PMID 18492024·Liver Int·2009
8-other
A case-control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure.
PMID 19590182·Blood Purif·2009
8-other
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.
PMID 19319382·Can J Gastroenterol·2009
4-observational
Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.
PMID 19291180·Liver Int·2009
8-other
Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007.
PMID 18822078·Liver Int·2008
8-other
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.
PMID 18088245·J Viral Hepat·2008
3-trial
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C.
PMID 18666223·Hepatology·2008
3-trial
Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial.
PMID 18304883·Clin Gastroenterol Hepatol·2008
4-observational
The clinical impact and cost implication of endoscopic ultrasound on use of endoscopic retrograde cholangiopancreatography in a Canadian university hospital.
PMID 18299731·Can J Gastroenterol·2008
8-other
Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians.
PMID 18701944·Can J Gastroenterol·2008
4-observational
Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience.
PMID 18925305·Can J Gastroenterol·2008
4-observational
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin.
PMID 18397386·Aliment Pharmacol Ther·2008
4-observational
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients.
PMID 18467185·Clin Gastroenterol Hepatol·2008
3-trial
Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.
PMID 17567927·Crit Care·2007
6-review
The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
PMID 17403073·Am J Gastroenterol·2007
6-review
ABO-incompatible liver transplantation for critically ill adult patients.
PMID 17521384·Transpl Int·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4803 WARD RD
WHEAT RIDGE, CO 80033 - Phone
- (303) 338-4545
Quick Facts
- NPI
- 1659690311
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile